Pharmaceutical companies eye patent cliff in rear view mirror
Several big pharma companies still have to face the pain of significant revenue erosion over the next couple of years as their blockbuster products lose patent protection and endure the prospects of generic competition. However, by and large most have managed to navigate themselves beyond this tough terrain thanks to creative business strategies designed to secure consistent future growth.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter